These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26214430)

  • 21. [Experience of 97 patients with moyamoya disease: long-term follow-up at a single center].
    Liu XJ; Zhang D; Wang S; Zhao YL; Wang R; Zhao JZ
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(9):604-7. PubMed ID: 22800948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
    Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L
    Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superficial temporal artery-middle cerebral artery bypass combined with encephalo-duro-myo-synangiosis in treating moyamoya disease: surgical techniques, indications and midterm follow-up results.
    Xu B; Song DL; Mao Y; Gu YX; Xu H; Liao YJ; Liu CH; Zhou LF
    Chin Med J (Engl); 2012 Dec; 125(24):4398-405. PubMed ID: 23253709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human hematopoietic progenitor in bone marrow and peripheral blood.
    Messner HA
    Stem Cells; 1998; 16 Suppl 1():93-6. PubMed ID: 11012151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
    Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
    Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood stem cells differ from bone marrow stem cells in cell cycle status, repopulating potential, and sensitivity toward hyperthermic purging in mice mobilized with cyclophosphamide and granulocyte colony-stimulating factor.
    Wierenga PK; Setroikromo R; Kamps G; Kampinga HH; Vellenga E
    J Hematother Stem Cell Res; 2002 Jun; 11(3):523-32. PubMed ID: 12183837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.
    Gaia S; Smedile A; Omedè P; Olivero A; Sanavio F; Balzola F; Ottobrelli A; Abate ML; Marzano A; Rizzetto M; Tarella C
    J Hepatol; 2006 Jul; 45(1):13-9. PubMed ID: 16635534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Curative effect of surgery on moyamoya disease: an analysis of 47 patients].
    Chen F; Chen Y; Zeng M; Tan Z; Huang J; Wang J; Liang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):652-656. PubMed ID: 28690222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors.
    Cecyn KZ; Schimieguel DM; Kimura EY; Yamamoto M; Oliveira JS
    Transfus Apher Sci; 2009 Jun; 40(3):159-67. PubMed ID: 19380254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
    Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
    Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
    Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysis.
    Rinn JP; Schwella N; Wollmer E; Jaques G; Heinzel-Gutenbrunner M; Strassmann G; Gross MW; Movassaghi K; Neubauer A; Ritter M
    Ann Hematol; 2006 Jan; 85(1):38-44. PubMed ID: 16012838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies.
    Dabusti M; Lanza F; Campioni D; Castagnari B; Tieghi A; Moretti S; Punturieri M; De Angeli C; Spanedda R; Ferrazzi E; Castoldi G
    J Hematother Stem Cell Res; 2003 Aug; 12(4):425-34. PubMed ID: 12965079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.
    Lazarus HM; Haynesworth SE; Gerson SL; Caplan AI
    J Hematother; 1997 Oct; 6(5):447-55. PubMed ID: 9368181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.
    Bolwell BJ; Goormastic M; Yanssens T; Dannley R; Baucco P; Fishleder A
    Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Suyani E; Aki SZ; Acar K; Yagci M; Sucak GT
    J Clin Apher; 2010; 25(5):280-6. PubMed ID: 20623783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to minimize ischemic complication related to swollen temporalis muscle following indirect revascularization surgery in moyamoya disease: a technical report.
    Joo SP; Kim TS; Moon HS
    J Neurol Surg A Cent Eur Neurosurg; 2014 May; 75(3):231-5. PubMed ID: 23532610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.